Clopidogrel in acute coronary syndromes: can the cost effectiveness improve?

Circulation. 2003 Aug 26;108(8):e56; author reply e56. doi: 10.1161/01.CIR.0000086778.57755.6A.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Disease
  • Aspirin / therapeutic use
  • Clopidogrel
  • Coronary Disease / drug therapy*
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors / economics*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Risk
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / economics*
  • Ticlopidine / therapeutic use*
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Ticlopidine
  • Aspirin